Mestinon retard 180 mg
Country: Germany
Language: German
Source: BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Pyridostigminbromid
Available from:
CC - Pharma GmbH (8029457)
Dosage:
180 mg
Pharmaceutical form:
Retardtablette
Composition:
Teil 1 - Retardtablette; Pyridostigminbromid (00701) 180 Milligramm
Administration route:
zum Einnehmen
Authorization status:
zugelassen
Authorization date:
2022-04-11
